2018
DOI: 10.1016/j.bcp.2018.07.039
|View full text |Cite
|
Sign up to set email alerts
|

Cardamonin, a natural flavone, alleviates inflammatory bowel disease by the inhibition of NLRP3 inflammasome activation via an AhR/Nrf2/NQO1 pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
75
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 125 publications
(77 citation statements)
references
References 56 publications
2
75
0
Order By: Relevance
“…The antioxidants SOD and NQO-1 directly eliminate free superoxide radicals to protect against lipid peroxidation [50,51]. Previous reports of acute gut inflammation in the DSS model observed a significant increase in lipid peroxidation and reduced levels of antioxidant enzymes (NQO-1 and SOD) [18,19,[52][53][54][55][56], which were replicated in the present study. We also observed a significant reduction in MDA levels after treatment with idebenone, which is consistent with a previous report where idebenone effectively suppressed lipid peroxidation in brain mitochondria [57].…”
Section: Discussionsupporting
confidence: 87%
See 1 more Smart Citation
“…The antioxidants SOD and NQO-1 directly eliminate free superoxide radicals to protect against lipid peroxidation [50,51]. Previous reports of acute gut inflammation in the DSS model observed a significant increase in lipid peroxidation and reduced levels of antioxidant enzymes (NQO-1 and SOD) [18,19,[52][53][54][55][56], which were replicated in the present study. We also observed a significant reduction in MDA levels after treatment with idebenone, which is consistent with a previous report where idebenone effectively suppressed lipid peroxidation in brain mitochondria [57].…”
Section: Discussionsupporting
confidence: 87%
“…This adaptive response is cytoprotective and enhances desensitisation against cytotoxicity and oxidative damage. There is some evidence that activation of the Nrf-2/NQO-1 redox pathway via pharmacological pre-conditioning can ameliorate DSS-induced inflammation in mice [17][18][19]. Current treatment of ulcerative colitis with non-steroidal anti-inflammatory drugs (NSAIDS), allopurinol, corticosteroids, immunosuppressant and biological agents show potential adverse effects, such as steroid dependency and infections [20][21][22][23].…”
Section: Introductionmentioning
confidence: 99%
“…Nrf2 inducers are under development for a variety of inflammatory, metabolic, degenerative, and neoplastic diseases 65 . The induction of Nrf2 signaling by cardamonin that we observe is consistent with prior reports in the literature [66][67][68] . In this regard, NRF2 levels and target gene expression are elevated in skin fibroblasts derived from long-lived Snell dwarf mice, likely contributing to the multiplex stress resistance observed in these cells 37 .…”
Section: Discussionsupporting
confidence: 93%
“…DSS-induced colitis was performed as previously described. 18 Female C57BL/6 mice were fed with 2.5% DSS (dissolved in sterile distilled water) for 7 days, and followed by sterile distilled water alone for another 3 days. The mice were randomly divided into the following groups: Normal group, DSS group, arctigenin (25, 50 mg/kg) group, and NaB (200 mg/kg) group.…”
Section: Induction Of Dss-and Tnbs-induced Colitis In Mice and Drugmentioning
confidence: 99%
“…TNBS-induced colitis was performed as previously described. 18 Female BALB/c mice were deprived of food for 8-12 hours, given with free access to 5% glucose, and anesthetized with avertin (290 mg/kg, i.p.). Then, a flexible catheter was carefully inserted into the colons of mice, and TNBS (1.5 mg dissolved in 100 ĀµL of 40% ethanol) was slowly administered.…”
Section: Induction Of Dss-and Tnbs-induced Colitis In Mice and Drugmentioning
confidence: 99%